SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Feb-24 6:43 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 12-Feb-24 | Option Exercise | 6,000 | $4.63 | $27,780.00 | 100% 0 to 6.0K | |
14-Feb-24 6:43 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 12-Feb-24 | Planned Option Sale | 6,000 | $31.97 | $191,849.00 | (100%) 6.0K to 0 | |
10-Jan-24 8:35 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 10-Jan-24 | Option Exercise | 6,000 | $4.63 | $27,780.00 | 100% 0 to 6.0K | |
10-Jan-24 8:35 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 10-Jan-24 | Planned Option Sale | 6,000 | $23.86 | $143,144.00 | (100%) 6.0K to 0 | |
11-Dec-23 7:01 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 11-Dec-23 | Option Exercise | 6,000 | $4.63 | $27,780.00 | 100% 0 to 6.0K | |
11-Dec-23 7:01 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 11-Dec-23 | Planned Option Sale | 6,000 | $20.07 | $120,422.00 | (100%) 6.0K to 0 | |
14-Nov-23 10:00 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 10-Nov-23 | Option Exercise | 7,000 | $4.63 | $32,410.00 | 100% 0 to 7.0K | |
14-Nov-23 10:00 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 10-Nov-23 | Planned Option Sale | 7,000 | $15.24 | $106,700.00 | (100%) 7.0K to 0 | |
25-Feb-19 8:44 PM View: | Achaogen, Inc. (AKAO) | 21-Feb-19 | Market Sale | 1,063 | $0.89 | $946.07 | (< 1%) 285.8K to 284.74K | 12% |
07-Feb-19 8:00 PM View: | Achaogen, Inc. (AKAO) | 05-Feb-19 | Market Sale | 818 | $1.35 | $1,104.30 | (< 1%) 286.62K to 285.8K | 32% |
23-Jan-19 5:13 PM View: | Achaogen, Inc. (AKAO) | 18-Jan-19 | Grant | 187,800 | -- | -- | 190% 98.82K to 286.62K | |
23-Jan-19 10:00 PM View: | Achaogen, Inc. (AKAO) | 31-Oct-18 | Grant | 75,000 | -- | -- | 315% 23.82K to 98.82K | |
28-Jun-18 4:18 PM View: | Achaogen, Inc. (AKAO) | 26-Jun-18 | Grant | 1,300 | -- | -- | 6% 22.97K to 24.27K | |
28-Jun-18 4:18 PM View: | Achaogen, Inc. (AKAO) | 26-Jun-18 | Market Sale | 450 | $9.59 | $4,315.50 | (2%) 24.27K to 23.82K | 90% |